0       0

2015 ISHLT Annual Meeting and Scientific Sessions


CCS45d - CONCURRENT SESSION 45: Candidate Selection- The Who, When and Why -- PDE 5 Inhibition With Udenafil Improves Left Ventricular Systolic/Diastolic Function and Exercise Capacity in Patients With Chronic Systolic Heart Failure: A 12-Week, Randomized, Double-


Apr 18, 2015 9:00am ‐ Apr 18, 2015 9:15am

Description

Presentation Includes
 

  • National Heart Failure Admissions and Associated Mortality Trends in Adults With Congenital Heart Disease in the United States, 1998-2011
  • Evolution of Status 1A Heart Transplant Candidates
  • Improvement of Waiting List Survival Among Patients With End-Stage Heart Failure (ESHF) Listed for Heart Transplantation (HT) - Analysis of OPTN/UNOS Data 1990-2013
  • PDE 5 Inhibition With Udenafil Improves Left Ventricular Systolic/Diastolic Function and Exercise Capacity in Patients With Chronic Systolic Heart Failure: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial (Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure) (ULTIMATE-SHF)
  • Results of Jehovah’s Witnesses Undergoing Surgical Treatment of Advanced CHF
  • Outcomes of Heart Transplantation in Adults With Amyloidosis: UNOS Registry Analysis

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content